MétaCan
Menu
Back to cohort
Record W4388501085 · doi:10.1186/s13054-023-04717-x

Bayesian methods: a potential path forward for sepsis trials

2023· article· en· W4388501085 on OpenAlexaffabout
George Tomlinson, Ali Al‐Khafaji, Steven A. Conrad, Faith Factora, Debra Foster, Claude Galphin, Kyle J. Gunnerson, Sobia Khan, Roopa Kohli‐Seth, Paul McCarthy, Nikhil Meena, Ronald G. Pearl, Jean-Sébastien Rachoin, Ronald Rains, Michael G. Seneff, Mark Tidswell, Paul M. Walker, John A. Kellum

Bibliographic record

VenueCritical Care · 2023
Typearticle
Languageen
FieldMedicine
TopicSepsis Diagnosis and Treatment
Canadian institutionsTornado Spectral Systems (Canada)Iridian Spectral Technologies (Canada)Public Health OntarioUniversity of Toronto
Fundersnot available
KeywordsMedicineSeptic shockBayesian probabilityStatistical powerRandomized controlled trialSepsisIntensive care medicineClinical trialShock (circulatory)StatisticsEmergency medicineInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Given the success of recent platform trials for COVID-19, Bayesian statistical methods have become an option for complex, heterogenous syndromes like sepsis. However, study design will require careful consideration of how statistical power varies using Bayesian methods across different choices for how historical data are incorporated through a prior distribution and how the analysis is ultimately conducted. Our objective with the current analysis is to assess how different uses of historical data through a prior distribution, and type of analysis influence results of a proposed trial that will be analyzed using Bayesian statistical methods. METHODS: We conducted a simulation study incorporating historical data from a published multicenter, randomized clinical trial in the US and Canada of polymyxin B hemadsorption for treatment of endotoxemic septic shock. Historical data come from a 179-patient subgroup of the previous trial of adult critically ill patients with septic shock, multiple organ failure and an endotoxin activity of 0.60-0.89. The trial intervention consisted of two polymyxin B hemoadsorption treatments (2 h each) completed within 24 h of enrollment. RESULTS: In our simulations for a new trial of 150 patients, a range of hypothetical results were observed. Across a range of baseline risks and treatment effects and four ways of including historical data, we demonstrate an increase in power with the use of clinically defensible incorporation of historical data. In one possible trial result, for example, with an observed reduction in risk of mortality from 44 to 37%, the probability of benefit is 96% with a fixed weight of 75% on prior data and 90% with a commensurate (adaptive-weighting) prior; the same data give an 80% probability of benefit if historical data are ignored. CONCLUSIONS: Using Bayesian methods and a biologically justifiable use of historical data in a prior distribution yields a study design with higher power than a conventional design that ignores relevant historical data. Bayesian methods may be a viable option for trials in critical care medicine where beneficial treatments have been elusive.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.247
metaresearch head score (Gemma)0.419
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.753
Threshold uncertainty score0.929

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2470.419
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0050.004
Bibliometrics0.0040.003
Science and technology studies0.0010.005
Scholarly communication0.0060.008
Open science0.0050.005
Research integrity0.0070.013
Insufficient payload (model declined to judge)0.0140.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.241
GPT teacher head0.523
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designTheoretical or conceptual
DomainMethods
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations15
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueCritical CareSame topicSepsis Diagnosis and TreatmentFrench-language works237,207